MedTrace Logo

Evaluation of Alcon Ladarvision Wavefront-Guided PRK

NCT00412295 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-07-23

No results posted yet for this study

Summary

The purpose of this study is to:

1. determine the safety of wavefront guided PRK
2. evaluate the efficacy of wavefront guided PRK
3. evaluate the differences in visual quality after treatment of wavefront guided PRK

Conditions

  • Myopia

Interventions

DEVICE

Alcon Ladarvision (Wavefront-guided PRK)

Wavefront-guided PRK using Alcon Ladarvision

Sponsors & Collaborators

  • Walter Reed Army Medical Center

    lead FED

Principal Investigators

  • STEVEN SCHALLHORN, MD · United States Naval Medical Center, San Diego

  • KRAIG S BOWER, MD · Walter Reed Army Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00412295 on ClinicalTrials.gov